These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
743 related articles for article (PubMed ID: 8158680)
1. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680 [TBL] [Abstract][Full Text] [Related]
2. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441 [TBL] [Abstract][Full Text] [Related]
3. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658 [TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the head and neck: a 5- to 20-year experience with preoperative chemotherapy, uncompromised surgery, and selective radiotherapy. Loré JM; Kaufman S; Sundquist N; Chary KK Ann Surg Oncol; 2003 Jul; 10(6):645-53. PubMed ID: 12839849 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. Zorat PL; Paccagnella A; Cavaniglia G; Loreggian L; Gava A; Mione CA; Boldrin F; Marchiori C; Lunghi F; Fede A; Bordin A; Da Mosto MC; Sileni VC; Orlando A; Jirillo A; Tomio L; Pappagallo GL; Ghi MG J Natl Cancer Inst; 2004 Nov; 96(22):1714-7. PubMed ID: 15547184 [TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer. Zidan J; Kuten A; Rosenblatt E; Robinson E Oral Oncol; 1997 Mar; 33(2):129-35. PubMed ID: 9231171 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Laramore GE; Scott CB; al-Sarraf M; Haselow RE; Ervin TJ; Wheeler R; Jacobs JR; Schuller DE; Gahbauer RA; Schwade JG Int J Radiat Oncol Biol Phys; 1992; 23(4):705-13. PubMed ID: 1618662 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma. Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI; N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864 [TBL] [Abstract][Full Text] [Related]
13. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. Vermorken JB; Remenar E; van Herpen C; Gorlia T; Mesia R; Degardin M; Stewart JS; Jelic S; Betka J; Preiss JH; van den Weyngaert D; Awada A; Cupissol D; Kienzer HR; Rey A; Desaunois I; Bernier J; Lefebvre JL; N Engl J Med; 2007 Oct; 357(17):1695-704. PubMed ID: 17960012 [TBL] [Abstract][Full Text] [Related]
15. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study. Lewin F; Damber L; Jonsson H; Andersson T; Berthelsen A; Biörklund A; Blomqvist E; Evensen JF; Hansen HS; Hansen O; Jetlund O; Mercke C; Modig H; Overgaard M; Rosengren B; Tausjö J; Ringborg U Radiother Oncol; 1997 Apr; 43(1):23-8. PubMed ID: 9165133 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study. Chougule PB; Suk S; Chu QD; Leone L; Nigri PT; McRae R; Lekas M; Barone A; Bhat D; Bellino J Cancer; 1994 Oct; 74(7):1927-32. PubMed ID: 8082098 [TBL] [Abstract][Full Text] [Related]
18. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166 [TBL] [Abstract][Full Text] [Related]
20. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. Pinnarò P; Cercato MC; Giannarelli D; Carlini P; Del Vecchio MR; Impiombato FA; Marzetti F; Milella M; Cognetti F Ann Oncol; 1994 Jul; 5(6):513-9. PubMed ID: 7918123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]